Page 51 - CASA Bulletin of Anesthesiology 2022; 9(3)-1 (1)
P. 51
Vol. 9, No 3, 2022
highlighted the notion of multi-organ cross-talk and the difficulty in tackling MOD in the
intensive care units .
9
Accumulating studies have demonstrated that necroptosis is a key cell death mechanism
underlying ischaemia-reperfusion organ injury 10-11 and chronic inflammatory disease 12-14 .
Necroptosis also plays a central role in remote, multiple organ injury, as our group showed that
15
necroptosis underlies lung injury that develops secondary to renal transplantation . The salient
observation that inhibition of necroptosis prevents sterile (non-pathogen induced) inflammation
suggests necroptosis as a form of inflammatory, immunogenic cell death, and highlights the
therapeutic potential of targeting necroptosis in the prevention and treatment of multiple organ
dysfunction and inflammation 16-18 . The precise molecular mechanisms linking necroptosis to
sterile inflammation remain uncertain and elucidating such molecular interactions in the context
of postoperative MOD will open up novel avenues for postoperative patient management.
Therefore, further mechanistic studies will be needed to identify potential therapeutic targets for
the prevention and treatment of postoperative MOD/MOF. However, at the present, clinicians
are strongly advised to carefully assess patients’ conditions including their neurologic functional
19
status before surgery , to take any necessary measures to protect organ vital functions and to
ensure vulnerable or frail patients can recover from traumatic surgery.
Reference
1. Nepogodiev D, Martin J, Biccard B, Makupe A, Bhangu A, National Institute for Health Research Global Health
Research Unit on Global S. Global burden of postoperative death. Lancet 2019; 393: 401.
2. Lobo SM, Rezende E, Knibel MF, et al. Early determinants of death due to multiple organ failure after noncardiac
surgery in high-risk patients. Anesth Analg 2011; 112: 877-83.
3. Shoemaker WC, Appel PL, Kram HB. Tissue oxygen debt as a determinant of lethal and nonlethal postoperative
organ failure. Crit Care Med 1988; 16: 1117-20.
4. Harward TR, Welborn MB, 3rd, Martin TD, et al. Visceral ischemia and organ dysfunction after
thoracoabdominal aortic aneurysm repair. A clinical and cost analysis. Ann Surg 1996; 223: 729-34; discussion 34-
6.
5. Futier E, Lefrant JY, Guinot PG, et al. Effect of Individualized vs Standard Blood Pressure Management
Strategies on Postoperative Organ Dysfunction Among High-Risk Patients Undergoing Major Surgery: A
Randomized Clinical Trial. JAMA 2017; 318: 1346-57.
6. Thompson JS, Baxter BT, Allison JG, Johnson FE, Lee KK, Park WY. Temporal patterns of postoperative
complications. Arch Surg 2003; 138: 596-602; discussion -3.
7. Deitch EA. Multiple organ failure. Pathophysiology and potential future therapy. Ann Surg 1992; 216: 117-34.
8. Doi K, Rabb H. Impact of acute kidney injury on distant organ function: recent findings and potential therapeutic
targets. Kidney Int 2016; 89: 555-64.
9. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan,
China. Lancet 2020; 395: 497-506.
10. Linkermann A, Brasen JH, Himmerkus N, et al. Rip1 (receptor-interacting protein kinase 1) mediates
necroptosis and contributes to renal ischemia/reperfusion injury. Kidney Int 2012; 81: 751-61.
11. Zhao H, Jaffer T, Eguchi S, Wang Z, Linkermann A, Ma D. Role of necroptosis in the pathogenesis of solid
organ injury. Cell Death Dis 2015; 6: e1975.
12. Welz PS, Wullaert A, Vlantis K, et al. FADD prevents RIP3-mediated epithelial cell necrosis and chronic
intestinal inflammation. Nature 2011; 477: 330-4.
13. Gunther C, Martini E, Wittkopf N, et al. Caspase-8 regulates TNF-alpha-induced epithelial necroptosis and
terminal ileitis. Nature 2011; 477: 335-9.
P a g e 50 | 63